Home  /  Resource Library  /  Differences in evidentiary requirements for oncology drug assessments across health technology assessment bodies in Germany, Spain, and France, the European Medicines Agency, and the EU Health Technology assessment regulation

Differences in evidentiary requirements for oncology drug assessments across health technology assessment bodies in Germany, Spain, and France, the European Medicines Agency, and the EU Health Technology assessment regulation

Study explored evidence requirements for HTA assessments in various agencies.